PetMed Express CFO Departs, Interim Appointed
Ticker: PETS · Form: 8-K · Filed: Aug 5, 2024 · CIK: 1040130
| Field | Detail |
|---|---|
| Company | Petmed Express Inc (PETS) |
| Form Type | 8-K |
| Filed Date | Aug 5, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $300,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-departure, cfo-appointment, compensation
Related Tickers: PETS
TL;DR
CFO out at PETS, interim steps in. Keep an eye on the next steps.
AI Summary
PetMed Express, Inc. announced on August 2, 2024, the departure of its Chief Financial Officer, Jeffrey W. Atwood, effective August 5, 2024. The company also announced the appointment of Michael J. Slifka as interim CFO. Additionally, the company reported on executive compensation arrangements.
Why It Matters
A CFO departure can signal financial strategy shifts or internal challenges, while an interim appointment suggests a search for a permanent replacement is underway.
Risk Assessment
Risk Level: medium — A sudden CFO departure can indicate underlying issues or uncertainty within the company's financial management.
Key Players & Entities
- PetMed Express, Inc. (company) — Registrant
- Jeffrey W. Atwood (person) — Departing Chief Financial Officer
- August 5, 2024 (date) — Effective date of CFO departure
- Michael J. Slifka (person) — Interim Chief Financial Officer
- August 2, 2024 (date) — Date of report
FAQ
Who has been appointed as the interim Chief Financial Officer?
Michael J. Slifka has been appointed as the interim Chief Financial Officer.
When is Jeffrey W. Atwood's departure as CFO effective?
Jeffrey W. Atwood's departure as CFO is effective August 5, 2024.
What is the company's principal executive office address?
The company's principal executive office is located at 420 South Congress Avenue, Delray Beach, Florida 33445.
What is the filing date of this Current Report?
The filing date of this Current Report is August 5, 2024.
What are the main items reported in this 8-K filing?
This 8-K filing reports on the departure of a director or certain officer, election of directors, appointment of certain officers, compensatory arrangements of certain officers, Regulation FD Disclosure, and Financial Statements and Exhibits.
Filing Stats: 983 words · 4 min read · ~3 pages · Grade level 10.6 · Accepted 2024-08-05 16:27:52
Key Financial Figures
- $300,000 — k will receive an annual base salary of $300,000, he will be entitled to participate in
Filing Documents
- pets-20240802.htm (8-K) — 32KB
- pets-20240802xexx101.htm (EX-10.1) — 19KB
- pets-20240805xexx991pressr.htm (EX-99.1) — 10KB
- 0001040130-24-000062.txt ( ) — 192KB
- pets-20240802.xsd (EX-101.SCH) — 2KB
- pets-20240802_lab.xml (EX-101.LAB) — 21KB
- pets-20240802_pre.xml (EX-101.PRE) — 12KB
- pets-20240802_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure On August 5, 2024, the Company issued a press release announcing the appointment of Mr. Krulik as Chief Accounting Officer of the Company. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information in this Item 7.01 and the related information in Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section and shall not be deemed incorporated by reference in any filing made by the Company under the Securities Act or the Exchange Act except as set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Offer letter by and between PetMed Express, Inc. and Doug Krulik 99.1 Press Release dated August 5 , 2024 104 Cover Page Interactive Data File (formatted as Inline XBRL) * * * 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 5, 2024 PETMED EXPRESS, INC. By: /s/ Sandra Compos Name: Sandra Campos Title: Chief Executive Officer and President 3